I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rousseau, Emma
163
results:
Search for persons
X
Format
Online (163)
Mediatypes
Articles (Online) (29)
Bookchapter (Online) (2)
OpenAccess-fulltext (130)
Audio (Online) (2)
Languages
english (148)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is h..:
Gough, Sheryl M.
;
Flanagan, John J.
;
Teh, Jessica
...
Clinical Cancer Research. , 2024
Link:
https://doi.org/10.1158/..
?
2
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo De..:
Berlin, Michael
;
Cantley, Jennifer
;
Bookbinder, Mark
...
Journal of Medicinal Chemistry. 67 (2024) 2 - p. 1262-1313 , 2024
Link:
https://doi.org/10.1021/..
?
3
Development of Liposome Systems for Enhancing the PK Proper..:
Kou, Ponien
;
Levy, Elizabeth S.
;
Nguyen, An D.
...
Pharmaceutics. 15 (2023) 8 - p. 2098 , 2023
Link:
https://doi.org/10.3390/..
?
4
Selective PROTAC-mediated degradation of SMARCA2 is efficac..:
Cantley, Jennifer
;
Ye, Xiaofen
;
Rousseau, Emma
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
5
Effects of GS-9876, a novel spleen tyrosine kinase inhibito..:
Clarke, Astrid S.
;
Rousseau, Emma
;
Wang, Kelly
...
Thrombosis Research. 170 (2018) - p. 109-118 , 2018
Link:
https://doi.org/10.1016/..
?
6
TP508, a thrombin‐derived peptide, modulates TLR‐4 dependen..:
Rousseau, Emma
;
Smoke, Chris
;
Zepp, Jarod
..
The FASEB Journal. 23 (2009) S1 - p. , 2009
Link:
https://doi.org/10.1096/..
?
7
TP508 accelerates fracture repair by promoting cell growth ..:
Li, Xinmin
;
Wang, Hali
;
Touma, Edward
...
Biochemical and Biophysical Research Communications. 364 (2007) 1 - p. 187-193 , 2007
Link:
https://doi.org/10.1016/..
?
8
Genetic network and pathway analysis of differentially expr..:
Li, Xinmin
;
Wang, Hali
;
Touma, Edward
...
Journal of Cellular Biochemistry. 100 (2006) 2 - p. 527-543 , 2006
Link:
https://doi.org/10.1002/..
?
9
The gene structure of the Drosophila melanogaster homolog o..:
Rousseau, Emma
;
Goldstein, Elliott S.
Gene. 272 (2001) 1-2 - p. 315-322 , 2001
Link:
https://doi.org/10.1016/..
?
10
Development of Liposome Systems for Enhancing the PK Proper..:
Kou, Ponien
;
Levy, Elizabeth S
;
Nguyen, An D
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458015/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
Selective PROTAC-mediated degradation of SMARCA2 is efficac..:
Cantley, Jennifer
;
Ye, Xiaofen
;
Rousseau, Emma
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649729/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
RGD-dependent binding of TP508 to integrin αvβ3 mediates ce..:
Derkach, Dmitry N
;
Wadekar, Subhagya A
;
Perkins, Kim B
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540356/. , 2010
Link:
http://www.ncbi.nlm.nih...
?
13
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo De..:
Michael Berlin
;
Jennifer Cantley
;
Mark Bookbinder
...
doi:10.1021/acs.jmedchem.3c01781.s002. , 2024
Link:
https://doi.org/10.1021/..
?
14
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo De..:
Michael Berlin
;
Jennifer Cantley
;
Mark Bookbinder
...
doi:10.1021/acs.jmedchem.3c01781.s001. , 2024
Link:
https://doi.org/10.1021/..
?
15
Development of Liposome Systems for Enhancing the PK Proper..:
Ponien Kou
;
Elizabeth S. Levy
;
An D. Nguyen
...
https://www.mdpi.com/1999-4923/15/8/2098. , 2023
Link:
https://doi.org/10.3390/..
1-15
